Investors
A hybrid company built for durable growth.
Services revenue, owned IP and four large, impact-led sectors.
De-risked by design
Services revenue funds product development, so the company doesn’t depend on one product or one funding round. Tested through COVID-19 and the generative AI shift.
Large, essential sectors
Healthcare, education, agriculture and life sciences, aligned with the UN Sustainable Development Goals and India’s national digital programmes.
Owned and partnered IP
PurpleGene®, built and run by our edtech company Ritebook, plus products in healthcare, agriculture and AI agents for the pharmaceutical industry.
Proven delivery
Clinical decision support used in 471+ facilities through ClinAlly, global pharma clients and 50,000+ students reached in 2024.